Description: Khiron Life Sciences Corp. operates as an integrated medical and cannabis company in Latin America and Europe. It operates through Health Services, Medical Cannabis Products, and Wellbeing Products segments. The company focuses on the cultivation, production, distribution, and export of tetrahydrocannabinol and cannabidiol (CBD) medical cannabis. It also operates a network of health centers and satellite clinics under the ILANS and Zerenia brands; develops CBD-based cosmeceutical products under the Kuida brand name; and operates Zerenia clinic in Medellin and Peru. Khiron Life Sciences Corp. was incorporated in 2012 and is headquartered in Vancouver, Canada.
Home Page: khiron.ca
500 Burrard Street
Vancouver,
BC
V6C 2B5
Canada
Phone:
705 527 3564
Officers
| Name | Title |
|---|---|
| Dr. Alvaro Francisco Torres | Co-Founder, CEO & Director |
| Ms. Franziska Katterbach | Pres of Khiron Europe |
| Mr. Swapan Kakumanu ACA, ACWA, CGA | Corp. Sec. |
| Ms. Helen Bellwood A.C.A. | Interim Chief Financial Officer |
| Mr. Manuel Buendia | VP of Operations |
| Mr. Luis Chavez | Country Mang. of Mexico |
| Mr. Marco Algorta | Country Mang. of Uruguay |
| Mr. Juan Diego Alvarez | VP of Regulations |
Exchange: F
Country: DE : Germany
Currency: Euro (€)
| Forward PE: | 0 |
|---|---|
| Trailing PE: | 0 |
| Price-to-Book MRQ: | 0.3499 |
| Price-to-Sales TTM: | 0.5789 |
| IPO Date: | |
| Fiscal Year End: | December |
| Full Time Employees: | 0 |